Pure Bioscience, Inc. (PURE) shareholders
PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30
$0.07−0.01 (-12.10%)
Close on Oct 19, 2026Market cap $8.67MP/E –Yield –
Ownership
Who owns Pure Bioscience's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jeffrey Scott Kitchell | President, Corporate Secretary | 12,998 | 0.01% | Nov 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Robert F. Bartlett CEO, Director | Mar 22, 2023 | Buy | +50,000 | $0.16 | $8.00K | 50,000 |
| Bernard Blotner Director | Mar 21, 2023 | Buy | +10,000 | $0.13 | $1.30K | 10,000 |
| Tom Y. Lee Chief Executive Officer, Director, 10% owner | Dec 15, 2022 | Buy | +50,000 | $0.13 | $6.50K | 5,001,843 |
| Tom Y. Lee Chief Executive Officer, Director, 10% owner | Jul 15, 2022 | Award | +15,741,666 | $0.15 | $2.36M | 29,143,617 |
| Tom Y. Lee Chief Executive Officer, Director, 10% owner | Jul 15, 2022 | Award | +6,000,000 | $0.15 | $900.00K | 6,000,000 |
| David Rendall Director | Jul 15, 2022 | Award | +325,000 | $0.15 | $48.75K | 402,371 |
| Ivan Chen Director | Jul 15, 2022 | Award | +300,000 | $0.15 | $45.00K | 750,000 |
| Tom Y. Lee Chief Executive Officer, Director, 10% owner | Mar 21, 2022 | Buy | +185,000 | $0.20 | $37.00K | 4,951,843 |
| Tom Y. Lee Chief Executive Officer, Director, 10% owner | Mar 17, 2022 | Buy | +13,250 | $0.18 | $2.39K | 4,766,843 |
| Tom Y. Lee Chief Executive Officer, Director, 10% owner | Mar 16, 2022 | Buy | +21,227 | $0.18 | $3.82K | 4,753,593 |
| Tom Y. Lee Chief Executive Officer, Director | Jun 16, 2021 | Buy | +35,998 | $0.43 | $15.48K | 4,732,366 |
| Tom Y. Lee Chief Executive Officer, Director | Dec 24, 2020 | Buy | +851 | $0.65 | $553 | 4,696,368 |
| Tom Y. Lee Chief Executive Officer, Director | Dec 22, 2020 | Buy | +45,299 | $0.66 | $29.90K | 4,695,517 |
| Tom Y. Lee Chief Executive Officer, Director | Dec 21, 2020 | Buy | +7,859 | $0.68 | $5.34K | 4,650,218 |
| Dale Okuno Director | Dec 19, 2020 | Sale | −748,880 | $0.29 | $217.18K | 5,560,540 |
| Tom Y. Lee Chief Executive Officer, Director | Dec 17, 2020 | Buy | +4,712 | $0.65 | $3.06K | 4,642,359 |
| Tom Y. Lee Chief Executive Officer, Director | Dec 16, 2020 | Buy | +20,000 | $0.67 | $13.40K | 4,637,647 |
| Tom Y. Lee Chief Executive Officer, Director | Jun 24, 2020 | Other | −10,732,222 | – | – | 13,401,951 |
| Tom Y. Lee Chief Executive Officer, Director | Jun 22, 2020 | Buy | +13,124 | $1.72 | $22.57K | 4,617,647 |
| Tom Y. Lee Chief Executive Officer, Director | Jun 19, 2020 | Buy | +10,000 | $1.85 | $18.50K | 4,604,523 |
| Tom Y. Lee Chief Executive Officer, Director | Jun 18, 2020 | Buy | +30,000 | $1.75 | $52.50K | 4,594,523 |
| Tom Y. Lee Chief Executive Officer, Director | Jun 17, 2020 | Buy | +26,876 | $1.61 | $43.27K | 4,564,523 |
| Tom Y. Lee Chief Executive Officer, Director | Jun 16, 2020 | Buy | +70,000 | $1.62 | $113.40K | 4,537,647 |
| Tom Y. Lee Chief Executive Officer, Director | Jun 15, 2020 | Buy | +60,000 | $1.82 | $109.20K | 4,467,647 |
| Tom Y. Lee Chief Executive Officer, Director | Jun 12, 2020 | Buy | +45,157 | $1.91 | $86.25K | 4,407,647 |
| Thomas Richard Myers Chief Operating Officer | May 1, 2020 | Award | +500,000 | – | – | 587,500 |
| Dale Okuno Director | Mar 9, 2020 | Award | +1,551,724 | $0.29 | $450.00K | 7,072,264 |
| Tom Y. Lee Director | Mar 9, 2020 | Award | +2,243,103 | $0.29 | $650.50K | 24,134,173 |
| Ivan Chen Director | Mar 9, 2020 | Award | +179,311 | $0.29 | $52.00K | 450,000 |
| Tom Y. Lee Director | Feb 14, 2020 | Gift | −1,000,000 | – | – | 21,891,070 |
| Tom Y. Lee Director | Feb 14, 2020 | Gift | +1,000,000 | – | – | 1,000,000 |
| Dale Okuno Director | Dec 31, 2019 | Sale | −40,000 | $0.28 | $11.20K | 5,520,540 |
| Tom Y. Lee Director | Dec 19, 2019 | Buy | +754,884 | $0.29 | $218.92K | 22,891,070 |
| Tom Y. Lee Director | Oct 2, 2019 | Award | +1,000,000 | $0.29 | $290.00K | 22,136,186 |
| Dale Okuno Director | Oct 2, 2019 | Award | +862,068 | $0.29 | $250.00K | 6,309,420 |
| Dale Okuno Director | Oct 2, 2019 | Buy | +862,068 | $0.29 | $250.00K | 6,309,420 |
| Tom Y. Lee Director | Oct 2, 2019 | Buy | +1,000,000 | $0.29 | $290.00K | 22,136,186 |
| Tom Y. Lee Director | Jul 2, 2019 | Gift | +1,000,000 | – | – | 1,000,000 |
| Tom Y. Lee Director | Jul 2, 2019 | Gift | −1,000,000 | – | – | 21,136,186 |
| Tom Y. Lee Director | Jul 1, 2019 | Gift | +1,000,000 | – | – | 1,000,000 |
| Tom Y. Lee Director | Jul 1, 2019 | Gift | −1,000,000 | – | – | 22,136,186 |
| Ivan Chen Director | May 9, 2019 | Buy | +120,689 | $0.29 | $35.00K | 270,689 |
| Dale Okuno Director | May 9, 2019 | Buy | +862,068 | $0.29 | $250.00K | 5,447,352 |
| Dale Okuno Director | May 9, 2019 | Buy | +714,285 | $0.35 | $250.00K | 5,299,569 |
| Ivan Chen Director | May 9, 2019 | Buy | +100,000 | $0.35 | $35.00K | 250,000 |
| Dale Okuno Director | Feb 19, 2019 | Option exercise | +213,333 | $0.35 | $74.67K | 4,585,284 |
| Tom Y. Lee Director | Feb 19, 2019 | Option exercise | +2,133,333 | $0.35 | $746.67K | 23,136,186 |
| Tom Y. Lee Director | Aug 16, 2018 | Buy | +2,336,187 | $0.45 | $1.05M | 21,002,853 |
| Henry R. Lambert Chief Executive Officer, Director | Aug 13, 2018 | Award | +200,000 | – | – | 698,056 |
| Ivan Chen Director | Jun 28, 2018 | Award | +150,000 | – | – | 150,000 |
| Henry R. Lambert Chief Executive Officer, Director | Jan 12, 2018 | Sale | −677 | $0.93 | $630 | 518,379 |
| Henry R. Lambert Chief Executive Officer, Director | Jan 12, 2018 | Sale | −9,000 | $0.94 | $8.46K | 509,379 |
| Henry R. Lambert Chief Executive Officer, Director | Jan 12, 2018 | Sale | −11,323 | $0.90 | $10.19K | 498,056 |
| Henry R. Lambert Chief Executive Officer, Director | Jan 11, 2018 | Sale | −2,000 | $0.94 | $1.88K | 519,056 |
| Henry R. Lambert Chief Executive Officer, Director | Jan 10, 2018 | Sale | −18,500 | $0.94 | $17.39K | 521,056 |
| Tom Y. Lee Director | Dec 29, 2017 | Buy | +18,666,666 | – | – | 18,666,666 |
| Franchise Brands, LLC 10% owner | Dec 29, 2017 | Sale | −18,666,666 | – | – | 0 |
| Elisabeth Hagen Director | Nov 2, 2017 | Award | +150,000 | – | – | 150,000 |
| Tom Y. Lee Director | Sep 25, 2017 | Option exercise | +208,038 | $0.40 | $83.22K | 4,362,490 |
| William Otis Director | Sep 25, 2017 | Option exercise | +9,066 | $0.60 | $5.44K | 181,732 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-54.8%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Pure Bioscience's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?